Nova Labs Sermorelin (Growth Hormone Releasing Peptide)

Sermorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), investigated for its role in stimulating endogenous growth hormone release via pituitary signalling pathways. It is studied in experimental and clinical contexts for its interaction with growth hormone dynamics and pulsatile secretion patterns.

Sermorelin functions by engaging the body’s natural regulatory mechanisms involved in growth hormone signalling.

Key Features:

• GHRH analogue involved in endogenous growth hormone signalling

• Investigated for stimulation of pulsatile growth hormone release

• Studied in relation to growth hormone regulatory pathways

• Associated in research with sleep-related hormone cycles

• Explored in metabolic and endocrine-focused research settings

• Commonly included in longevity and performance-related research contexts

Suggested Use:
For use under the guidance of a qualified professional. Protocols vary depending on application and individual requirements.

Storage:

• Lyophilized form: Store in a cool, dry place (15–25°C), protected from light

• After reconstitution: Store at 2–8°C. Do not freeze. Use within a limited timeframe

Important Information:
Sermorelin has been studied in clinical settings for specific indications; however, this product is intended for controlled use within appropriate regulatory frameworks. Not recommended for individuals under 18, pregnant or breastfeeding individuals, or those with certain medical conditions. Ensure compliance with applicable regulations prior to use.